结直肠癌手术预康复可改善无病生存
该研究汇总3项预康复试验(2项随机对照试验、1项队列)共202例择期结直肠癌手术患者,比较预康复组与未预康复组的5年无病生存(DFS)和总生存(OS)。结果显示,Ⅲ期患者预康复组DFS优于对照组(73.4% vs 50.9%,P=0.044),预康复独立预测DFS改善(HR 0.45,95%CI 0.21-0.93),但OS无差异。
要点
- Ⅲ期结直肠癌患者预康复与5年DFS改善相关。
- 预康复独立预测DFS改善,校正分期等混杂因素后HR为0.45。
- 预康复未独立预测总生存,OS无显著差异。
核心结论
- 在结直肠癌手术患者中,预康复与Ⅲ期患者5年无病生存改善相关。
- 预康复未独立预测总生存,OS无显著差异。
研究设计与样本
- 汇总3项预康复试验(2项随机对照试验、1项队列)的池化数据。
- 纳入2009至2014年择期、活检证实、原发非转移性结直肠癌手术患者,均在加速康复程序内。
- 共202例患者,预康复组104例,未预康复组98例。
- 预康复中位持续时间29天(四分位距20-40)。
- 主要结局为5年无病生存和总生存,采用Kaplan-Meier曲线和多因素Cox回归分析。
主要发现
- 患者和肿瘤特征均衡,Ⅲ期占33%。
- 术后并发症和辅助化疗时间两组相似。
- 平均随访60.3个月(标准差26.2)。
- Ⅰ-Ⅲ期合并分析中,两组DFS相似(P=0.244)。
- Ⅲ期患者中,预康复组DFS为73.4%,对照组为50.9%(P=0.044)。
临床怎么用
- 对Ⅲ期结直肠癌手术患者,可考虑实施预康复以改善无病生存。
- 预康复方案为中位29天的多模式运动与营养干预。
- 预康复对总生存的获益尚未证实,需结合其他治疗策略。
局限性
- 研究为汇总3项试验的池化分析,非单一随机对照试验。
- 样本量有限,共202例。
- 作者指出该发现需未来试验确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to investigate the effect of prehabilitation on survival after colorectal cancer surgery. SUMMARY OF BACKGROUND DATA: Preoperative multimodal exercise and nutritional programs (prehabilitation) improve functional capacity and recovery following colorectal surgery. Exercise may also affect cancer outcomes by mediating the systemic inflammatory response. The effect of prehabilitation on cancer outcomes is unknown. METHODS: Pooled data from 3 prehabilitation trials (2 randomized controlled trials, 1 cohort) in patients undergoing elective, biopsy-proven, primary non-metastatic colorectal cancer surgery from 2009 to 2014 within an enhanced recovery program were analyzed. Patients were grouped into +prehab or-prehab. The primary outcomes were 5-year disease-free (DFS) and overall survival (OS). DFS and OS were analyzed using Kaplan-Meier curves and multiple Cox regression. RESULTS: A total of 202 patients were included (+prehab 104, -prehab 98). Median prehabilitation duration was 29 days (interquartile range 20-40). Patient and tumor characteristics were well-balanced (33% stage III). Postoperative complications and time to adjuvant chemotherapy were similar. Mean duration of follow-up was 60.3 months (standard deviation 26.2). DFS was similar for the combined group of stage I-III patients (P = 0.244). For stage III patients, prehabilitation was associated with improved DFS (73.4% vs 50.9%, P = 0.044). There were no differences in OS (P = 0.226). Prehabilitation independently predicted improved DFS (hazard ratio 0.45; 95% confidence interval, 0.21-0.93), adjusting for stage and other confounders. Prehabilitation did not independently predict OS. CONCLUSION: In this report, prehabilitation is associated with improved 5-year DFS in stage III colorectal cancer. This finding should be confirmed in future trials.
引用
- Trépanier M, Minnella EM, Paradis T, et al. Improved Disease-free Survival After Prehabilitation for Colorectal Cancer Surgery. Ann Surg. 2019. PMID: 31318793. doi:10.1097/SLA.0000000000003465
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。